Cardioloxía
Servicio
London School of Hygiene & Tropical Medicine
Londres, Reino UnidoPublicacións en colaboración con investigadores/as de London School of Hygiene & Tropical Medicine (15)
2022
-
Amphilimus- vs. zotarolimus-eluting stents in patients with diabetes mellitus and coronary artery disease: The SUGAR trial
European Heart Journal, Vol. 43, Núm. 13, pp. 1320-1330
-
Efficacy of empagliflozin in heart failure with preserved versus mid-range ejection fraction: a pre-specified analysis of EMPEROR-Preserved
Nature Medicine, Vol. 28, Núm. 12, pp. 2512-2520
-
Empagliflozin in the treatment of heart failure with reduced ejection fraction in addition to background therapies and therapeutic combinations (EMPEROR-Reduced): a post-hoc analysis of a randomised, double-blind trial
The Lancet Diabetes and Endocrinology, Vol. 10, Núm. 1, pp. 35-45
-
Rationale and design of the pragmatic clinical trial tREatment with Beta-blockers after myOcardial infarction withOut reduced ejection fracTion (REBOOT)
European heart journal. Cardiovascular pharmacotherapy, Vol. 8, Núm. 3, pp. 291-301
2021
-
Empagliflozin in heart failure with a preserved ejection fraction
New England Journal of Medicine, Vol. 385, Núm. 16, pp. 1451-1461
-
MEESSI-AHF risk score performance to predict multiple post-index event and post-discharge short-term outcomes
European Heart Journal: Acute Cardiovascular Care, Vol. 10, Núm. 2, pp. 142-152
-
Synergistic Impact of Systolic Blood Pressure and Perfusion Status on Mortality in Acute Heart Failure
Circulation. Heart failure, Vol. 14, Núm. 3, pp. e007347
2020
-
Baseline characteristics of patients with heart failure with preserved ejection fraction in the EMPEROR-Preserved trial
European Journal of Heart Failure, Vol. 22, Núm. 12, pp. 2383-2392
-
Second-Generation Drug-Eluting Stents in Diabetes (SUGAR) trial: Rationale and study design
American Heart Journal, Vol. 222, pp. 174-182
2019
-
Clinical Impact of the Polypill for Cardiovascular Prevention in Latin America: A Consensus Statement of the Inter-American Society of Cardiology
Global Heart, Vol. 14, Núm. 1, pp. 3-16.e1
2017
-
2-Year Outcomes of High Bleeding Risk Patients After Polymer-Free Drug-Coated Stents
Journal of the American College of Cardiology, Vol. 69, Núm. 2, pp. 162-171
-
Home blood pressure management intervention in low- To middle-income countries: Protocol for a mixed methods study
JMIR Research Protocols, Vol. 6, Núm. 10
2015
-
Polymer-free drug-coated coronary stents in patients at high bleeding risk
New England Journal of Medicine, Vol. 373, Núm. 21, pp. 2038-2047
2014
-
Long-term benefit of early pre-reperfusion metoprolol administration in patients with acute myocardial infarction: Results from the Metocard-CNIC trial (Effect of Metoprolol in Cardioprotection during an Acute Myocardial Infarction)
Journal of the American College of Cardiology, Vol. 63, Núm. 22, pp. 2356-2362
2013
-
Effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: The effect of Metoprolol in Cardioprotection during an Acute Myocardial Infarction (METOCARD-CNIC) Trial
Circulation, Vol. 128, Núm. 14, pp. 1495-1503